Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Akeso launches global Phase II trial of cadonilimab for IO-resistant liver cancer patients
Akeso begins a global Phase II trial of cadonilimab in advanced liver cancer. Find out how this bispecific IO drug could reshape second-line HCC therapy.
Kashiv BioSciences bets on Latin America with Cristália deal for Xolair biosimilar
Kashiv BioSciences partners with Brazil’s Cristália to commercialize omalizumab biosimilar ADL-018 in Latin America, targeting a $140M market opportunity.
Why Medicines Discovery Catapult and Crown Bioscience think their partnership will change oncology R&D
Discover how Medicines Discovery Catapult and Crown Bioscience are reshaping radiopharmaceutical drug discovery with a new integrated platform.
Why Japan’s review of Ferring’s bladder cancer gene therapy candidate could reshape urology
Discover how Ferring’s gene therapy nadofaragene firadenovec could transform NMIBC treatment in Japan after PMDA NDA acceptance.
Pulnovo Medical secures dual IDE approvals with CMS backing to advance PADN clinical trials in the U.S.
Pulnovo Medical gains FDA IDE and CMS coverage to launch PADN U.S. trials, signaling disruption in the pulmonary hypertension device market.
Acadia’s LOTUS study confirms long‑term benefits and manageable side‑effects of DAYBUE over 12 months in Rett syndrome
New real-world data shows DAYBUE improves Rett syndrome symptoms and is tolerable over 12 months. Find out what the LOTUS study reveals for patients and doctors.
Can PADN technology redefine treatment for pulmonary hypertension? Pulnovo’s trials begin in U.S.
Pulnovo Medical wins FDA IDE approvals and CMS backing for U.S. trials of its PADN system in pulmonary hypertension. Find out what this means for patients.
Can plixorafenib redefine thyroid cancer treatment? Inside FORE Biotherapeutics’ latest trial results
FORE Biotherapeutics reveals ATA 2025 data showing plixorafenib’s long-lasting effects in BRAF-altered thyroid cancers. See why it’s generating investor buzz.
Industry shake-up: Can Hercules’ new pharmacy chief solve America’s drug shortage crisis?
Hercules Pharmaceuticals appoints Elie Bahou to lead U.S. pharmacy strategy with a focus on AI, resilience, and national drug supply chain reform.
Inside the Pete Pharma–FABRX deal: Can 3D printing finally scale in compounding pharmacies?
Pete Pharma partners with FABRX to bring 3D printing to U.S. compounding pharmacies—find out how this could transform personalized medication delivery.